Concepedia

Tamás Schweighoffer

TS

23

Publications

1.2K

Citations

16

H-Index

1991

Active since

Affiliations

Research Institute of Molecular Pathology(Current)

Boehringer Ingelheim (Austria)

Novartis (Switzerland)

Novartis (Austria)

Novartis Institutes for BioMedical Research

Tamás Schweighoffer is an author at Research Institute of Molecular Pathology specializing in medicine, immunology, and cell biology.

ORCID

Top concepts

Publications per year

1991–2022

23

Publications

23

Selective expression of integrin <i>alpha</i> 4 <i>beta</i> 7 on a subset of human CD4+ memory T cells with Hallmarks of gut-trophism.

Tamás Schweighoffer, Yoichiro Tanaka, Mark Tidswell et al. · The Journal of Immunology · 1993 · 254 citations · Full text

CD44-Deficient Mice Develop Normally with Changes in Subpopulations and Recirculation of Lymphocyte Subsets

Ursula Protin, Tamás Schweighoffer, Wolfram Jochum et al. · The Journal of Immunology · 1999 · 197 citations · Full text

, , +16

Cancer vaccines: the interleukin 2 dosage effect.

Wolfgang Schmidt, Tamás Schweighoffer, E Herbst et al. · Proceedings of the National Academy of Sciences · 1995 · 127 citations · Full text

, , +17

Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: three consecutive stages may be required for successful tumor vaccination.

Gerd Maass, Wolfgang Schmidt, M Berger et al. · Proceedings of the National Academy of Sciences · 1995 · 95 citations · Full text

, , +17

SAP-Mediated Inhibition of Diacylglycerol Kinase α Regulates TCR-Induced Diacylglycerol Signaling

Gianluca Baldanzi, Andrea Pighini, Valentina Bettio et al. · The Journal of Immunology · 2011 · 51 citations · Full text

, , +17

Rows per page

1–5 of 23